These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12201840)

  • 1. Value of central analysis of leucocyte depletion quality control data within the National Blood Service, England.
    Beckman N; Cardigan R; Wallington T; Williamson LM
    Vox Sang; 2002 Aug; 83(2):110-8. PubMed ID: 12201840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of a national standardized approach for the enumeration of residual leucocytes in blood components.
    Cardigan R; Phipps A; Seghatchian J; Bashir S; Aynsley S; Beckman N; Barnett D; Reilly JT; Williamson LM
    Vox Sang; 2002 Aug; 83(2):100-9. PubMed ID: 12201839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control of leucoreduced cellular blood components in France.
    Chabanel A; Andreu G; Carrat F; Hervé P
    Vox Sang; 2002 Feb; 82(2):67-71. PubMed ID: 11906669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low level leucocyte counting: a critical variable in the validation of leucodepleted blood transfusion components as highlighted by an external quality assessment study.
    Barnett D; Goodfellow K; Ginnever J; Granger V; Whitby L; Reilly JT
    Clin Lab Haematol; 2001 Feb; 23(1):43-51. PubMed ID: 11422230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A national quality assessment scheme for counting residual leucocytes in unfixed leucodepleted products: the effect of standardisation and 48 hour storage.
    Krailadsiri P; Seghatchian J; Rigsby P; Bukasa A; Bashir S
    Transfus Apher Sci; 2002 Feb; 26(1):73-81. PubMed ID: 11931380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The United Kingdom National External Quality Assessment Scheme gating and standardization strategy for use in residual WBC counting of WBC-reduced blood components.
    Goodfellow KJ; Storie I; Granger V; Whitby L; Antcliffe J; Reilly JT; Barnett D
    Transfusion; 2002 Jun; 42(6):738-46. PubMed ID: 12147027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. French evaluation of conditions for the systematic implementation of leucocyte removal in labile blood products (LBP).
    Chamfly V
    Transfus Sci; 1998 Dec; 19(4):333-42. PubMed ID: 10351148
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenges in QA of leucodepleted blood component and current standard(s). Challenges in quality assurance of leukoreduced components.
    Dumont LJ
    Transfus Sci; 1998 Dec; 19(4):377-80. PubMed ID: 10351162
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of acridine orange and glutaraldehyde-fixed chicken red blood cells for absolute counting of residual white blood cells in leuco-depleted packed red blood cells.
    Noulsri E; Lerdwana S; Pattanapanyasat K
    Asian Pac J Allergy Immunol; 2012 Jun; 30(2):123-9. PubMed ID: 22830291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National French observatory of the quality of blood components for transfusion.
    Chabanel A; Masse M; Begue S;
    Transfus Clin Biol; 2008 Jun; 15(3):85-90. PubMed ID: 18524661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control of leucocyte-reduced blood components: overestimation of WBC content due to nucleated red blood cells.
    Fischer JC; Moog R; Giers G
    Vox Sang; 2012 Jan; 102(1):79-81. PubMed ID: 21564108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of a new filter for leucocyte depletion of platelet concentrate during component preparation.
    Christensen LD; Dickmeiss E
    Vox Sang; 1994; 67(3):267-71. PubMed ID: 7863626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukodepleted blood components: definition of a standard.
    Andreu G; Masse M; Royer SD; Tardivel R
    Transfus Sci; 1998 Dec; 19(4):381-3. PubMed ID: 10351163
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on leucocyte depletion of blood components by filtration.
    Pietersz RN; van der Meer PF; Seghatchian MJ
    Transfus Sci; 1998 Dec; 19(4):321-8. PubMed ID: 10351145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing effective working partnership with manufacturers.
    Pujol-Reyz A
    Transfus Sci; 1998 Dec; 19(4):375-6. PubMed ID: 10351161
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates.
    Wadhwa M; Krailadsiri P; Dilger P; Gaines Das R; Seghatchian MJ; Thorpe R
    Vox Sang; 2002 Aug; 83(2):125-36. PubMed ID: 12201842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International views on universal leucodepletion: the perspective in NBS, England.
    Wallington T
    Transfus Sci; 1998 Dec; 19(4):347-8. PubMed ID: 10351150
    [No Abstract]   [Full Text] [Related]  

  • 18. Leucodepletion process performance variation: is it dependent on the batch of filters, the processing centre or the counting technology?
    Beckman N; Seghatchian J
    Transfus Sci; 2000 Oct; 23(2):113-8. PubMed ID: 11035272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new one-platform flow cytometric method for residual cell counting in platelet concentrates.
    Schmidt M; Spengler HP; Lambrecht B; Hourfar MK; Seifried E; Tonn T
    Transfusion; 2009 Dec; 49(12):2604-11. PubMed ID: 19682343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid and reliable flow cytometric routine method for counting leucocytes in leucocyte-depleted platelet concentrates.
    Backteman K; Ledent E; Berlin G; Ernerudh J
    Vox Sang; 2002 Jul; 83(1):29-34. PubMed ID: 12100386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.